XSS in IBM Common Licensing

CVE-2026-1025

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Vulnerability class: XSS (Cross-Site Scripting)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.

EPSS exploit prediction

EPSS: 0.003 (16.8th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 17th percentile — 16.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-1025: held from 0.002 to 0.003.

EPSS over last 30 days · oldest: 0.002 · newest: 0.003 · change: +0.001

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-1025?
CVE-2026-1025 is a medium-severity vulnerability in IBM Common Licensing, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2026-09-18.
How severe is CVE-2026-1025?
Medium severity. CVSS v3 base score is 6.1 out of 10.